Disease mechanisms in rheumatology--tools and pathways: plasmacytoid dendritic cells and their role in autoimmune rheumatic diseases.
about
Cause and consequences of the activated type I interferon system in SLEEvaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy.Human effector B lymphocytes express ARID3a and secrete interferon alpha.Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation.Biological and targeted therapies of systemic lupus erythematosus: evidence and the state of the art.Systemic lupus erythematosus: still a challenge for physicians.IFN-α production by plasmacytoid dendritic cell associations with polymorphisms in gene loci related to autoimmune and inflammatory diseases.Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus.TLR7/8 activation in neutrophils impairs immune complex phagocytosis through shedding of FcgRIIA.Self-dsDNA in the pathogenesis of systemic lupus erythematosus.Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.Dual role of CpG-stimulated B cells in the regulation of dendritic cells: comment on the article by Berggren et al.Report of the inaugural Interferon Research Summit: interferon in inflammatory diseases.The Absent in Melanoma 2-Like Receptor IFN-Inducible Protein 16 as an Inflammasome Regulator in Systemic Lupus Erythematosus: The Dark Side of Sensing Microbes.Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis: A tool to stratify a high versus low risk of active tuberculosis?Interferon-α Inhibition by Intravenous Immunoglobulin Is Independent of Modulation of the Plasmacytoid Dendritic Cell Population in the Circulation: Comment on the Article by Wiedeman et al
P2860
Q28075268-EBB7F714-1CEA-4CD8-B7CD-3481EA6FFEF6Q35008162-17E65D49-A53C-4563-AAE3-AC2E1C2809C1Q38291271-11B58190-C7E5-4752-A313-639EED032E28Q38673434-ED1681EB-B84A-42AE-AD29-3A12B78C637BQ38690844-450C33AB-4CFC-4D4F-B6E6-A7AA2BD32F4FQ38866356-9072C25B-CC7D-49F2-9CA5-D259BD1525BEQ42154442-22280AFA-87AC-4631-A9F8-B7CAAEC8F499Q46061403-BE11E6C0-C784-48E2-AD8A-9642625A0DD2Q47094567-71FD352A-E6E4-423F-9383-FFC723C4A1DDQ47912211-264EBDAD-335D-4238-9927-D40A03202E7FQ48166465-B82C5F72-E9D5-4040-BCE8-E947B315D710Q51000066-E11BDBBC-9E60-4E31-9DCA-0990E1E31394Q55383884-F7F49144-239A-4E42-ACAF-AF74205B6DCAQ55436021-6770A7CD-4D72-4C65-A53C-15D216E9CF35Q58601433-ADC9B35B-131C-4ABE-9216-6B485D20CCD0Q58861214-07F0B1D4-9CC8-426A-BE59-E55BF1627C14
P2860
Disease mechanisms in rheumatology--tools and pathways: plasmacytoid dendritic cells and their role in autoimmune rheumatic diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Disease mechanisms in rheumato ...... autoimmune rheumatic diseases.
@en
type
label
Disease mechanisms in rheumato ...... autoimmune rheumatic diseases.
@en
prefLabel
Disease mechanisms in rheumato ...... autoimmune rheumatic diseases.
@en
P2093
P2860
P356
P1476
Disease mechanisms in rheumato ...... autoimmune rheumatic diseases.
@en
P2093
Gunnar V Alm
Lars Rönnblom
Maija-Leena Eloranta
P2860
P304
P356
10.1002/ART.37821
P577
2013-04-01T00:00:00Z